In the published article, there were three instances where there was a mistake in the cited references. This is because the references were renumbered sequentially after revision of manuscript.
In the Results section, the sentence “By comparison, a non-linear dose–response meta-analysis with 13 eligible studies (37-39, 42, 48, 55-57, 60, 61, 66, 83, 84)” has been changed to “By comparison, a non-linear dose–response meta-analysis with 13 eligible studies (37, 38, 42, 47, 48, 55-57, 60, 61, 66, 83, 84)”.
In the Results section, the sentence “Another negative linearity association also existed between the CDDD and the incidence risk of endometrial, corpus uteri, and cervical cancer, from four eligible studies (30, 33, 34, 72)” has been changed to “Another negative linearity association also existed between the CDDD and the incidence risk of endometrial, corpus uteri, and cervical cancer, from four eligible studies (28, 45, 49, 86)”.
In the Discussion section, the sentence “Moreover, different from several studies that have found that prolactin may encourage the development of estrogen receptor (ER)-positive tumors (89) and higher risk in in situ (51, 85)” has been changed to “Moreover, different from several studies that have found that prolactin may encourage the development of estrogen receptor (ER)-positive tumors (89) and higher risk in in situ (52, 85)”.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
antidepressant, depression, breast cancer, gynecological cancer, Incidence, meta-analysis, systematic review, dose-response analysis
Citation
Zhuang Y, Pang X, Qi Y, Zhang T, Cao G, Xue H, Xu Y, Xie S, Liu Y, Wang Y, Li Y, Xiong Y, Li Y and Shen H (2022) Corrigendum: The incidence risk of breast and gynecological cancer by antidepressant use: A systematic review and dose–response meta-analysis of epidemiological studies involving 160,727 patients. Front. Oncol. 12:1072594. doi: 10.3389/fonc.2022.1072594
Received
17 October 2022
Accepted
25 October 2022
Published
08 November 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2022 Zhuang, Pang, Qi, Zhang, Cao, Xue, Xu, Xie, Liu, Wang, Li, Xiong, Li and Shen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hui Shen, huishenlj@hotmail.com; Yuanyuan Li, lyy05_2012@163.com
This article was submitted to Cancer Epidemiology and Prevention, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.